# Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea

> **NCT06776432** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Shionogi** · enrollment: 60 (actual)

## Conditions studied

- Sleep Apnea

## Interventions

- **DRUG:** Sivopixant
- **DRUG:** Placebo
- **DRUG:** Acetazolamide
- **DRUG:** SASS-001

## Key facts

- **NCT ID:** NCT06776432
- **Lead sponsor:** Shionogi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-04-02
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06776432

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06776432, "Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea". Retrieved via AI Analytics 2026-08-09 from https://api.ai-analytics.org/clinical/NCT06776432. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*